Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / BIOS Capital Management, LP
Form 13F · Q2 2026

BIOS Capital Management, LP

CIK 1813845Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$42M
Reported book value
9
Positions
7
Quarters on record
Top 50
Positions

BIOS Capital Management, LP — holdings

Top 6 positions of 9, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ACTU Actuate Therapeutics Inc10.0M+0.0%$15M36.9%
2IRD Opus Genetics Inc3.7M+0.0%$15M36.3%
3CGTX Cognition Therapeutics Inc6.0M+0.0%$7M16.6%
4RNTX Rein Therapeutics Inc3.0M+50.4%$3M7.4%
5LTRN Lantern Pharma Inc249,397−71.1%$1M2.5%
6INAB In8Bio Inc80,957−51.8%$114,1490.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.